DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

[Maternal complications of fetal hydrops]

Author(s): Brandenburg H, de Krijger RR, Visser W, Wessels MW, Steegers EA

Affiliation(s): Afd. Verloskunde en Vrouwenziekten, Erasmus Medisch Centrum, locatie Dijkzigt, Dr. Molewaterplein 40, 3015 GD Rotterdam. brandenburg@gyna.azr.nl

Publication date & source: 2002-12-07, Ned Tijdschr Geneeskd., 146(49):2367-70.

Publication type: Case Reports

Three women, aged 28, 27 and 25 years, two primigravidae and one woman who had given birth to a hydropic child previously, had four pregnancies with hydrops of the foetus and the placenta: two (in the same patient) due to foetal cardiomyopathy and two with foetal heart block. The patients developed severe oedema and preeclampsia. After the delivery they recovered well. Since the introduction of anti-D rhesus immunoprophylaxis, foetal hydrops has become less frequent. The resulting maternal complications (the maternal hydrops syndrome and enlarged polycystic ovaries) are therefore less well-known. Serious maternal complications occur in around 50% of cases of foetal hydrops. Careful monitoring of the maternal condition in cases of foetal hydrops is therefore warranted.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017